Search research articles
Contact Us
Filters
Showing results (1-10 of 22) with videos related to
Page
of 3
Sort By:
Journal of Comparative Effectiveness Research
|
April 26, 2018
Budget impact analysis of long-acting injectable aripiprazole once-monthly 400 mg in bipolar I disorder in the USA
Margarida Augusto, Mallik Greene, Maëlys Touya, et al.
Journal of Medical Economics
|
September 7, 2018
A real-world analysis of healthcare costs and relative risk of hyperprolactinemia associated with antipsychotic treatments in the United States
Martin Cloutier, Mallik Greene, Maëlys Touya, et al.
Current Medical Research and Opinion
|
April 27, 2021
Adherence and persistence among patients with major depressive disorder enrolled in the vortioxetine tAccess Patient Support Program
Debra F Lawrence, Janna Manjelievskaia, Lambros Chrones, et al.
Journal of Comparative Effectiveness Research
|
April 26, 2018
Cost-effectiveness of long-acting injectable aripiprazole once-monthly 400 mg in bipolar I disorder in the USA
Margarida Augusto, Mallik Greene, Maëlys Touya, et al.
Journal of Comparative Effectiveness Research
|
August 22, 2018
Impact of initiating long-acting injectable antipsychotics on hospitalization in patients with bipolar I disorder
Tingjian Yan, Mallik Greene, Eunice Chang, et al.
Current Medical Research and Opinion
|
October 24, 2017
All-cause hospitalization and associated costs in patients with schizophrenia or bipolar disorder initiating long-acting injectable antipsychotics
Tingjian Yan, Mallik Greene, Eunice Chang, et al.
BMC Psychiatry
|
March 2, 2022
Incremental burden of relapse in patients with major depressive disorder: a real-world, retrospective cohort study using claims data
Maëlys Touya, Debra F Lawrence, Anne Kangethe, et al.
BMC Health Services Research
|
August 7, 2021
Incremental burden of comorbid major depressive disorder in patients with type 2 diabetes or cardiovascular disease: a retrospective claims analysis
Anne Kangethe, Debra F Lawrence, Maëlys Touya, et al.
Journal of Medical Economics
|
September 13, 2017
Medication adherence and discontinuation of long-acting injectable versus oral antipsychotics in patients with schizophrenia or bipolar disorder
Mallik Greene, Tingjian Yan, Eunice Chang, et al.
Advances in Therapy
|
September 13, 2018
Medication Adherence and Discontinuation of Aripiprazole Once-Monthly 400 mg (AOM 400) Versus Oral Antipsychotics in Patients with Schizophrenia or Bipolar I Disorder: A Real-World Study Using US Claims Data
Tingjian Yan, Mallik Greene, Eunice Chang, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 22) with videos related to
Sort By:
Page
of 3
Journal of Comparative Effectiveness Research
|
April 26, 2018
Budget impact analysis of long-acting injectable aripiprazole once-monthly 400 mg in bipolar I disorder in the USA
Margarida Augusto, Mallik Greene, Maëlys Touya, et al.
Journal of Medical Economics
|
September 7, 2018
A real-world analysis of healthcare costs and relative risk of hyperprolactinemia associated with antipsychotic treatments in the United States
Martin Cloutier, Mallik Greene, Maëlys Touya, et al.
Current Medical Research and Opinion
|
April 27, 2021
Adherence and persistence among patients with major depressive disorder enrolled in the vortioxetine tAccess Patient Support Program
Debra F Lawrence, Janna Manjelievskaia, Lambros Chrones, et al.
Journal of Comparative Effectiveness Research
|
April 26, 2018
Cost-effectiveness of long-acting injectable aripiprazole once-monthly 400 mg in bipolar I disorder in the USA
Margarida Augusto, Mallik Greene, Maëlys Touya, et al.
Journal of Comparative Effectiveness Research
|
August 22, 2018
Impact of initiating long-acting injectable antipsychotics on hospitalization in patients with bipolar I disorder
Tingjian Yan, Mallik Greene, Eunice Chang, et al.
Current Medical Research and Opinion
|
October 24, 2017
All-cause hospitalization and associated costs in patients with schizophrenia or bipolar disorder initiating long-acting injectable antipsychotics
Tingjian Yan, Mallik Greene, Eunice Chang, et al.
BMC Psychiatry
|
March 2, 2022
Incremental burden of relapse in patients with major depressive disorder: a real-world, retrospective cohort study using claims data
Maëlys Touya, Debra F Lawrence, Anne Kangethe, et al.
BMC Health Services Research
|
August 7, 2021
Incremental burden of comorbid major depressive disorder in patients with type 2 diabetes or cardiovascular disease: a retrospective claims analysis
Anne Kangethe, Debra F Lawrence, Maëlys Touya, et al.
Journal of Medical Economics
|
September 13, 2017
Medication adherence and discontinuation of long-acting injectable versus oral antipsychotics in patients with schizophrenia or bipolar disorder
Mallik Greene, Tingjian Yan, Eunice Chang, et al.
Advances in Therapy
|
September 13, 2018
Medication Adherence and Discontinuation of Aripiprazole Once-Monthly 400 mg (AOM 400) Versus Oral Antipsychotics in Patients with Schizophrenia or Bipolar I Disorder: A Real-World Study Using US Claims Data
Tingjian Yan, Mallik Greene, Eunice Chang, et al.
Page
of 3